www.fdanews.com/articles/85921-somaxon-s-silenor-effective-for-insomnia
SOMAXON'S SILENOR EFFECTIVE FOR INSOMNIA
April 10, 2006
Somaxon Pharmaceuticals has announced that results from its Phase III trial of Silenor demonstrated the drug is effective in treating insomnia.
The four-week trial showed that patients taking either a 3 mg or 6 mg Silenor tablet nightly had a longer, more efficient sleep than patients taking a placebo. Both dosages of Silenor were well-tolerated, and side effects were not observed.